Inicio › Trastorno depresivo mayor › California › Orange
Ensayos clínicos de Trastorno depresivo mayor en Orange, CA
13 estudios para Trastorno depresivo mayor buscan participantes en centros de Orange y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
ReclutandoFase 2
- PNS Clinical Research LLC dba ATP Clinical Research, Orange
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
ReclutandoFase 3
- ATP Clinical Research, Orange
- NRC Research Institute, Orange
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
ReclutandoFase 3
- ATP Clinical Research Orange County, Orange
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
ReclutandoFase 3
- ATP Clinical Research, Orange
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
ReclutandoFase 3
- NRC Research Institute, Orange
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 2
- Nrc Research Institute, Orange
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
ReclutandoFase 3
- Vanda Investigational Site, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
ReclutandoFase 4
- Neurocrine Clinical Site, Orange
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
ReclutandoFase 3
- Atp Clinical Research, Orange
- Nrc Research Institute, Orange
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Orange
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Orange
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
ReclutandoFase 2
- Autobahn Site #152, Orange
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutandoFase 3
- Neurocrine Clinical Site, Orange
Ensayos de Trastorno depresivo mayor en otras ciudades
- New York City, NY36 estudios
- Boston, MA31 estudios
- Atlanta, GA25 estudios
- Philadelphia, PA23 estudios
- Orlando, FL19 estudios
- Miami, FL18 estudios
- Chicago, IL17 estudios
- Tampa, FL17 estudios
- San Diego, CA16 estudios
- Houston, TX16 estudios
- Little Rock, AR14 estudios
- Austin, TX13 estudios
Otros estudios en Orange
- Cáncer de pulmón de células no pequeñas25 estudios
- Cáncer metastásico20 estudios
- Cáncer del colon y del recto16 estudios
- Cáncer de ovario16 estudios
- Cáncer de páncreas15 estudios
- Melanoma14 estudios
- Cáncer de hígado (carcinoma hepatocelular)14 estudios
- Cáncer de seno14 estudios
- Cáncer de pulmón14 estudios
- Cáncer de próstata14 estudios
- Cáncer de estómago13 estudios
- Cáncer (todos los tipos)13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.